Clinical Trials Logo

Post Thoracotomy Pain clinical trials

View clinical trials related to Post Thoracotomy Pain.

Filter by:
  • None
  • Page 1

NCT ID: NCT06331182 Recruiting - Dexmedetomidine Clinical Trials

Dexmedetomidine and Ketamine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain

Start date: March 26, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to compare the role of dexmedetomidine and ketamine as an adjuvant in external oblique intercostal plane block for post thoracotomy pain.

NCT ID: NCT04482192 Completed - Clinical trials for Post Thoracotomy Pain

Continuous Paravertebral Block by Intraoperative Direct Access Versus Systemic Analgesia for Postthoracotomy Pain Relief

Start date: June 15, 2015
Phase: Phase 3
Study type: Interventional

to evaluate the safety and efficacy of continuous paravertebral block by intraoperative direct access on postthoracotomy pain compared to systemic analgesia.

NCT ID: NCT03933592 Completed - Thoracic Epidural Clinical Trials

Ultrasound Guided Serratus Plane Block Versus Thoracic Epidural for Post Thoracotomy Pain

Start date: June 10, 2019
Phase: N/A
Study type: Interventional

This study aims at comparing the effect of serratus plane block versus thoracic epidural in patients undergoing thoracotomy for lung cancer surgery regarding pain control and possible side effects.

NCT ID: NCT03618225 Completed - Clinical trials for Post-thoracotomy Pain

Duloxetine Role in Reducing Opioid Consumption After Thoracotomy

Start date: August 15, 2018
Phase: Phase 4
Study type: Interventional

A total of 60 patients scheduled for thoracotomy with the aim of excision of pleural or lung cancer, will be randomized by the use of a computer-generated table of random numbers to receive duloxetine 60 mg orally 2 hours before the surgical procedure and at 24 hours after the surgical procedure or a placebo pill following the same time schedule.

NCT ID: NCT03415191 Completed - Clinical trials for Post Thoracotomy Pain

The Pre-Emptive Administration Of Ketamine for Controlling Post-thoracotomy Pain

Start date: January 5, 2012
Phase: N/A
Study type: Interventional

The goal of this paper is to evaluate whether the pre-emptive administration of Ketamine would potentiate the effect of intravenous morphine analgesia in management of post thoracotomy pain. This was a single center, double-blind, placebo controlled, parallel-group, prospective study. Patients were randomly assigned to receive 1 mg/kg ketamine (Ketamine Group) or an equivalent dose of normal saline (Placebo Group) before thoracotomy in 1:1 ratio. All patients received postoperatively intravenous morphine administration as additional analgesic regimen Primary end-point was pain relief measured with Visual Analogue Scale at rest. The secondary end-points were the reduction of inflammatory response expressed by plasma c-reactive protein levels, the morphine consumption, and the rate of side effects. The measurements were carried out 6; 12; 24; 36; and 48 post operative hours.

NCT ID: NCT01726205 Completed - Clinical trials for Post-thoracotomy Pain

Perioperative Pregabalin and Continuous Wound Infusion for Pain Control Following Thoracotomy

Start date: October 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the efficacy of pregabalin or pregabalin and continuous wound infusion versus placebo for analgesia following thoracotomy

NCT ID: NCT00934193 Withdrawn - Clinical trials for Post-thoracotomy Pain

Does Peri-Operative Gabapentin Reduce Chronic Post-Thoracotomy Pain?

Start date: July 2009
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to determine if gabapentin can decrease or prevent chronic post-thoracotomy pain.

NCT ID: NCT00623909 Withdrawn - Laser Therapy Clinical Trials

Laser Therapy in the Treatment of Post Thoracotomy Pain; A Pilot Study

Start date: January 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate the safety of the AvicennaTM class IV laser for application over the skin of human subjects. In addition, we seek to measure the effectiveness and utility of this class 4 laser therapy in the treatment of post-thoracotomy pain syndrome.